Important Update Understanding Recent Changes and the Future of Seed Access
Dear Community,
There has been a lot of discussion recently regarding the federal rescheduling of certain cannabis products to Schedule III. Because this is a major change, it is important that we clarify what this means for our community of breeders, home growers, and patients, and what it does not change.
What Rescheduling Means
As of April 22, 2026, the federal government has moved certain FDA approved and state licensed medical cannabis products to Schedule III. This primarily impacts the business operations of state regulated dispensaries and medical producers, largely by providing relief from specific federal tax burdens (Section 280E).
What Remains Unchanged
It is vital for our community to understand that this rescheduling does not change the laws regarding cannabis seeds. No Impact on Seeds This policy shift does not apply to the interstate commerce of seeds.
The November Deadline: The separate federal legislation passed in late 2025 (Section 781) remains in effect. As of
November 12, 2026, the interstate shipment of seeds from plants exceeding the 0.3% THC threshold will be treated as a federal offense.
Why We Still Need to Act
Because the recent rescheduling is limited to medical products, it does not offer protection to the independent seed banks, small-scale breeders, or the home gardens that form the backbone of our community.
We are currently advocating for H.R. 6209, the American Hemp Protection Act, which is the specific legislation needed to protect the preservation of genetics and patient access to reliable, consistent medicine. You can contact your local officials or two Senators. We cannot go backwards!